Trial description
FAST Forward is a randomised clinical trial testing a 1-week course of curative whole breast radiotherapy against a standard 3-week schedule in terms of local cancer control and late adverse effects in patients with early breast cancer. The lymphatic RT sub-study an extension to the FAST-Forward trial, which maintains its original design but whose entry is now restricted to patients prescribed radiotherapy to level I-III axilla and/or level IV axilla (supraclavicular fossa (SCF)) in addition to the breast/chest wall area.
Contact name
Dr Charlotte Coles
Trial start date
Monday, March 12, 2012
Trial end date
Tuesday, February 1, 2022
Trial tumour type
Show on Radiotherapy